RxDoctor Payments Data

Samuel Bayles, MD

Child & Adolescent Psychiatry · Little Rock, ARNPI 1043331010

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 61 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 15 manufacturers, the largest accounting for just 19.0% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $823, more than ten times the $38 reported in 2020.

$1,253in general payments, 2019–2025

Across 61 payments — averaging $20.55 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$238
  • Otsuka America Pharmaceutical, Inc.$219
  • Teva Pharmaceuticals USA, Inc.$130
  • Lundbeck LLC$130
  • Johnson & Johnson$110
  • Vanda Pharmaceuticals Inc.$56
  • plus $370 from 9 others

What the payments were for

  • Food & beverage$1,253100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,253 in reported general payments places this provider in the 75th percentile of 24 child & adolescent psychiatry providers in Arkansas.

See all child & adolescent psychiatry providers in Arkansas

Medicare billing

Part B allowed, 2024
$10,458
Medicare patients
34
Services billed
99

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
SuboxoneBuprenorphine Hcl/Naloxone Hcl11$2,913
Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl16$2,414
Buprenorphine Hcl21$499
Alprazolam13$121
Quetiapine Fumarate12$99
Fluoxetine Hcl11$80
Escitalopram Oxalate15$58

Paid to pharmacies, not to this prescriber.

Other child & adolescent psychiatry in Little Rock

See the full list for Arkansas

Where these figures come from

Is this you, or does something look wrong? →